 |
|
The Role of Meta-analysis in the Regulatory Process for Foods, Drugs, and Devices
Jesse A. Berlin, ScD;
Graham A. Colditz, MD, DrPH
JAMA. 1999;281:830-834.
Synthesis of research findings has a long-standing tradition in science. While synthesis is currently required in the US food and drug regulatory process, formal meta-analysis may substitute for a pivotal study or broaden the generalizability of drug efficacy through a preplanned meta-analysis. Preplanned meta-analysis of individual trials with deliberately introduced heterogeneity may maximize the generalizability of results from randomized trials. Combining observational data may help to support an alternative claim or to quantify adverse events. In this setting, methods to address potentially greater sources of bias are required. Overall, meta-analysis adds evidence through the synthesis study findings and permits examination of how treatment effects vary across of subgroups, such as age and sex, and across study settings.
Author Affiliations: Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia (Dr Berlin), and Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School and Technology Assessment Group, Harvard School of Public Health, Boston, Mass (Dr Colditz).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLES
Postmarketing Surveillance and Adverse Drug Reactions: Current Perspectives and Future Needs
Timothy Brewer and Graham A. Colditz
JAMA. 1999;281(9):824-829.
ABSTRACT
| FULL TEXT
Meta-analysis and Epidemiologic Studies in Drug Development and Postmarketing Surveillance
Robert Temple
JAMA. 1999;281(9):841-844.
EXTRACT
| FULL TEXT
March 3, 1999
JAMA. 1999;281(9):863-864.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Evidence and liberty: The promise of experimental criminology
Sherman
Criminal Justice 2009;9:5-28.
ABSTRACT
Meta-analysis: Its strengths and limitations
WALKER et al.
Cleveland Clinic Journal of Medicine 2008;75:431-439.
ABSTRACT
| FULL TEXT
Analysis of social epidemiology research on infectious diseases: historical patterns and future opportunities
Cohen et al.
J. Epidemiol. Community Health 2007;61:1021-1027.
ABSTRACT
| FULL TEXT
Evaluating the Quality of Trials of Hypothermic Circulatory Arrest Aortic Surgery
Shuhaiber
Asian Cardiovasc. Thorac. Ann. 2007;15:449-452.
ABSTRACT
| FULL TEXT
Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis: Meta-Analysis of Randomized Trials
Dibra et al.
J Am Coll Cardiol 2007;49:616-623.
ABSTRACT
| FULL TEXT
Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of Randomized Trials
Zhang et al.
JAMA 2006;296:1619-1632.
ABSTRACT
| FULL TEXT
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
Bongartz et al.
JAMA 2006;295:2275-2285.
ABSTRACT
| FULL TEXT
Generalizability of Studies on Mental Health Treatment and Outcomes, 1981 to 1996
Braslow et al.
Psychiatr. Serv. 2005;56:1261-1268.
ABSTRACT
| FULL TEXT
Challenges in Systematic Reviews That Assess Treatment Harms
Chou and Helfand
ANN INTERN MED 2005;142:1090-1099.
ABSTRACT
| FULL TEXT
The Continuing Unethical Conduct of Underpowered Clinical Trials
Halpern et al.
JAMA 2002;288:358-362.
ABSTRACT
| FULL TEXT
Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting
Stroup et al.
JAMA 2000;283:2008-2012.
ABSTRACT
| FULL TEXT
Meta-analysis and Epidemiologic Studies in Drug Development and Postmarketing Surveillance
Temple
JAMA 1999;281:841-844.
FULL TEXT
|
